Introduction {#s1}
============

Maintaining proper gene expression is critical for normal development and physiology. In addition to *de novo* transcription, mRNA stability substantially contributes to forming the landscape of expression in a cell. The nonsense-mediated mRNA decay (NMD) pathway is a *trans-*acting mechanism that destabilizes mRNAs, and is best known for its well-described role as a quality control system, degrading abnormal mRNAs containing premature termination codons (PTCs) ([@bib6]). NMD also degrades many wild-type endogenous mRNAs and thus is an important aspect of their post-transcriptional ([@bib33]). Loss of either of the core NMD genes *Upf1 (Rent1*) or *Upf2* causes lethality in most eukaryotes ([@bib22]; [@bib27]; [@bib29]; [@bib46]; [@bib47]), indicating regulation of mRNA stability by NMD is critical for viability. However, the relative contributions to lethality from ectopic stabilization of PTC-containing mRNAs or endogenous NMD targets in NMD mutants remains unclear ([@bib19]).

To identify which ectopically stabilized mRNAs are responsible for inducing lethality in NMD mutants, we performed an unbiased genetic suppressor screen seeking to restore viability in a *Drosophila* NMD mutant. To detect subtle increases in survival, we screened to suppress the lethality of animals mutant for the partially viable, hypomorphic *Upf2^25G^* allele, of which 10% survive to adulthood ([@bib8]; [@bib29]). We crossed this allele to heterozygous deficiencies to simultaneously reduce the mRNA abundance of several loci ([Figure 1A](#fig1){ref-type="fig"}). Of the 376 deficiencies tested, covering more than half the genome, \~10% suppressed NMD mutant lethality ([Figure 1B](#fig1){ref-type="fig"}, [Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). The suppression effect could not be explained by a reduction in overall mRNA load, as there was only a weak correlation between the increase in mRNAs expressed from a genomic region upon loss of NMD function and the strength of suppression when that region was removed by a deficiency ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}). Rather, deficiencies that suppressed NMD-mutant lethality clustered in three genomic regions ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). These findings suggest that NMD mutant lethality is not the result of a global excess of nonspecific mRNAs, but rather is mediated by specific genes residing within the few identified regions.10.7554/eLife.12876.003Figure 1.*Drosophila* suppressor screen identifies the *Gadd45* pathway as the inducer of NMD-mutant lethality.(**A**) Scheme to screen deficiencies for the suppression of *Upf2^25G^* partial lethality. The Deficiency Suppression Score (DSS) represents the relative difference in *Upf2^25G^* viability when crossed to a heterozygous deficiency (*Df*) compared to when crossed to a balancer (*Bal*) (See Methods). (**B**) DSS from 376 screened deficiencies ranked by score. A DSS greater than 0.1 (dotted line) indicates that deficiency suppresses *Upf2^25G^* lethality. (**C** and **E**) Candidate suppressing regions uncovering *Gadd45* (**C**) and *Mekk1* (**E**). DSSs are shown in parenthesis. Dotted lines denote extent of regions deleted by suppressing deficiencies but not non-suppressing deficiencies. Filled blocks on chromosomes indicate predicted gene spans, *Gadd45* pathway genes are indicated in red; suppressing deficiencies indicated in green, *sple-J1* has undefined breakpoints located within hashed regions. (**D** and **F**) NMD mutant adult viability in combination with *Gadd45^F17^* (**D**) or *Mekk1^Ur36^* (**F**) mutants. *Upf1^26A^* and *Upf2^7-5A^* are null alleles ([@bib12]; [@bib29]). p-value compared to controls determined by the test of equal or given proportions indicated. Error bars represent 95% confidence interval of the binomial distribution. n equals total number of animals scored in each cross.**DOI:** [http://dx.doi.org/10.7554/eLife.12876.003](10.7554/eLife.12876.003)10.7554/eLife.12876.004Figure 1---figure supplement 1.Reduced expression of specific loci, not overall mRNA abundance, produces NMD mutant suppression by deficiencies.(**A**) Map of 376 autosomal DrosDel deficiencies with an isogenic background and molecularly defined breakpoints ([@bib37]) and eight other deficiencies used to further test candidate suppressing regions without overlapping DrosDel deficiencies. 39 total deficiencies suppress *Upf2^25G^* lethality, shown in green. Regions deleted by any non-suppressing deficiencies were eliminated as candidate suppressing regions, removing false positives and reducing the size of the candidate intervals. The three candidate suppressing regions that are deleted only by suppressing deficiencies are indicated in black and labeled 1--3. (**B**) Each deficiency's Deficiency Suppression Score (DSS) compared to percent increase in RNA abundance in *Upf2^25G^* compared to wild-type from loci removed by that deficiency according to RNA-seq from [@bib8]. Trend line in red; statistics calculated using Pearson correlation test.**DOI:** [http://dx.doi.org/10.7554/eLife.12876.004](10.7554/eLife.12876.004)10.7554/eLife.12876.005Figure 1---figure supplement 2.Drosophila Gadd45 is an endogenous direct NMD target.(**A**) *Gadd45* mRNA expression in adults of the given genotypes measured by qRT-PCR. *Gadd45* mRNA expression is increased 16.7-fold in *Upf2^25G^* mutants, and is eliminated by *Gadd45^F17^* mutants. p-values display one-sided Student's t-test of indicated condition compared to control. Error bars represent 2 SEM. (**B**) Fluorescence of GFP transgenes with *SV40, Act5C*, or *Gadd45* 3' UTRs expressed by UAS driven by *Actin:GAL4* in *Upf2^+^* or *Upf2^25G^* third instar larvae. *SV40* and *Gadd45* 3' UTR constructs show significantly increased fluorescence in *Upf2^25G^* animals compared to *Upf2^+^*, indicating NMD-dependent post-transcriptional degradation of mRNAs containing these UTRs. The *Act5C* 3' UTR construct has similar fluorescence in both backgrounds, indicating NMD does not regulate the post-transcriptional stability of this UTR. Micrographs show dorsal views with anterior at top. (**C**) *MAL-A2, traL*, and *Gadd45* 5' and 3' fragment mRNA expression measured by qRT-PCR in *pcm^14^* null mutants ([@bib45]) normalized to controls. Transcript structures of a non-NMD-target, *maltase A2 (MAL-A2*); a known NMD-targeted transcript, the non-sex specific isoform of *transformer (traL*) ([@bib35]; [@bib29]); and the *Gadd45* transcript (note *Gadd45* has no introns). Open boxes indicate UTRs; grey boxes indicate coding regions. NMD targeting initiates endonucleolytic cleavage near the stop codon ([@bib14]), producing 5' and 3' fragments with unprotected ends, which are then subjected to degradation by cytoplasmic 3'-to-5' and 5'-to-3' exonucleases, respectively. qRT-PCR primer pairs 5' (red) and 3' (blue) to the cleavage site can be used to differentially measure the quantity of these fragments. The *Drosophila* 5'-to-3' exonuclease is encoded by the *XRN1* homologue *pacman (pcm*), and fragments 3' to an endonucleolytic NMD cleavage accumulate in *Drosophila* cells with reduced XRN1 activity ([@bib14]). The *MAL-A2* 3' primers show no difference in relative expression in *pcm^14^* mutants compared to the 5' primers, while *tra* and *Gadd45* have relatively increased levels of a 3' fragment in *pcm^14^* mutants, revealing endonucleolytic cleavage has occurred between the primer pairs, probably near the stop codon, indicative of NMD-initiated degradation. p-value between indicated samples using a two-sided Student's t-test are displayed. ns indicates a p-value greater than 0.05. Error bars represent 2 SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.12876.005](10.7554/eLife.12876.005)10.7554/eLife.12876.006Figure 1---figure supplement 3.F17 is a null allele of Gadd45.(**A**) *Gadd45^F17^* is an imprecise excision of the P-element *P{EPg}HP20647*, deleting a 894 bp region that includes the entire *Gadd45* coding region. *Gadd45^E8^* is a precise excision of the same P-element, leaving *Gadd45* intact. Coding region in grey; untranslated regions in white. Arrowhead indicates direction of transcription. (**B**) Adult viability of control and *Gadd45^F17^*mutants. p = 0.4463 between *Gadd45^F17^* and controls, using the test of equal or given proportions. Error bars represent 95% confidence interval of the binomial distribution. n equals total number of animals scored in each cross.**DOI:** [http://dx.doi.org/10.7554/eLife.12876.006](10.7554/eLife.12876.006)10.7554/eLife.12876.007Figure 1---figure supplement 4.Loss of Gadd45 does not restore NMD activity in NMD mutants.(**A**) Expression of the endogenous NMD target transcript *traL* ([@bib35]; [@bib29]) in control male, *Upf2^25G^/Y*, and *Upf2^25G^/Y; Gadd45^F17^*animals, measured by qRT-PCR. There is no significant difference in *traL* expression between *Upf2^25G^/Y* and *Upf2^25G^/Y; Gadd45^F17^*animals. p-values determined by one-sided Student's t-test between indicated conditions are displayed. ns indicates a p-value greater than 0.05. (**B**) Relative abundance of PTC-containing *Adh^n4^* ([@bib9]) and *dHR78^3^* ([@bib11]) allele mRNAs compared to wild-type allele mRNA abundance in animals heterozygous for *Adh^n4^*or *dHR78^3^*in each indicated genotype (stabilization of *dHR78^3^* was not determined in *Upf2^25G^*/*Y*; *Gadd45^F17^* animals). Neither reduction nor elimination of *Gadd45* restored destabilization of these alleles. p-values determined by two-sided Student's t-test between indicated conditions are displayed. ns indicates a p-value greater than 0.05. Error represents 2 SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.12876.007](10.7554/eLife.12876.007)

We expected that any specific genes mediating NMD-mutant lethality would have increased expression levels in an NMD mutant and be a direct NMD target. The only gene located within the suppressing regions to fit these criteria is *Gadd45* ([Figure 1C](#fig1){ref-type="fig"}, [Figure 1---figure supplement 2A--C](#fig1s2){ref-type="fig"}) ([@bib8]). To determine if NMD targeting of *Gadd45* mRNA is critical for viability, we generated a *Gadd45* null allele, *F17*, which completely removes the *Gadd45* coding region ([Figure 1---figure supplement 3A](#fig1s3){ref-type="fig"}) and eliminates *Gadd45* mRNA expression ([Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). As a heterozygote, *Gadd45^F17^* suppressed *Upf2^25G^*lethality as strongly as the corresponding deficiency identified by our screen ([Figure 1D](#fig1){ref-type="fig"}). We found that *Gadd45^F17^* homozygous mutants are fully viable ([Figure 1---figure supplement 3B](#fig1s3){ref-type="fig"}), allowing us to test complete loss of *Gadd45* for the suppression of NMD-mutant lethality. Homozygous *Gadd45^F17^* restored full viability to *Upf2^25G^*mutants, and remarkably even partially suppressed the complete lethality observed in null *Upf1* and *Upf2* mutants ([@bib12]; [@bib29]) ([Figure 1D](#fig1){ref-type="fig"}). Importantly, neither reducing nor eliminating *Gadd45* restored NMD function to *Upf2^25G^* mutants, as measured by the expression of both an endogenous NMD target ([Figure 1---figure supplement 4A](#fig1s4){ref-type="fig"}) and PTC-containing mRNAs ([Figure 1---figure supplement 4B](#fig1s4){ref-type="fig"}).

In mammals, GADD45 activates the MTK1/MEKK4 kinase in a well-defined stress response pathway ([@bib40]). Strikingly, the *Drosophila* MTK1 orthologue, *Mekk1*, resides within another *Upf2^25G^* suppressing region ([Figure 1E](#fig1){ref-type="fig"}). Similar to *Gadd45*, we found that *Mekk1* null mutants ([@bib20]) suppressed *Upf1* and *Upf2* mutant lethality ([Figure 1F](#fig1){ref-type="fig"}). This suppression was not as strong as that caused by a loss of *Gadd45*, revealing that although MEKK1 mediates NMD mutant lethality, it is likely that GADD45 has additional downstream effectors that influence viability. Overall, our findings reveal that increased *Gadd45* mRNA stability is the major factor inducing NMD mutant lethality, primarily via increased MEKK1 activity.

Activation of MTK1 in mammals triggers a MAPK signaling cascade that promotes apoptosis ([@bib40]). Over-expression of *Gadd45* in *Drosophila* also induces apoptosis ([@bib34]). Interestingly, *Drosophila* cells lacking NMD function show excess cell death in a variety of tissues ([@bib1]; [@bib12]; [@bib29]). To test if increased *Gadd45* contributes to this excess death, we used TUNEL staining to examine cell death in wing imaginal discs from *Upf2^25G^* mutant third instar larvae. This analysis revealed elevated levels of cell death compared to controls ([Figure 2A, B, E](#fig2){ref-type="fig"}), and this defect was completely suppressed by *Gadd45^F17^* ([Figure 2C--E](#fig2){ref-type="fig"}). To confirm that, this effect was not specific to the *Upf2* gene or *25G* allele, we examined the wing discs in mutants of another essential NMD gene, *Smg5*. We found that *Smg5* discs also showed elevated TUNEL signal, which was eliminated by loss of *Gadd45* ([Figure 2---figure supplement 1A--E](#fig2s1){ref-type="fig"}). These results demonstrate that excess *Gadd45* accounts for ectopic cell death in NMD mutant tissues.10.7554/eLife.12876.008Figure 2.Loss of Gadd45 suppresses NMD-mutant cell death.(**A **to **D**) DAPI (blue) and (**A'**to **D'**) TUNEL (red) staining in late 3^rd^ instar larval wing discs from control (**A**); *Upf2^25G^* (**B**); *Gadd45^F17^* (**C**); and *Upf2^25G^; Gadd45^F17^* (**D**) animals. (**A''** to **D''**) are 4x view of outlined section at the base of the blade of the wing disc from **A'-D'**, respectively. Scale bar represents 100 μm. (**E**) Relative TUNEL signal in control and mutant wing discs, normalized to control. p-value between indicated samples using a two-sided Student's t-test are displayed. ns indicates a p-value greater than 0.05. Error bars represent 2 SEM. n equals total number of discs scored. (**F** to **I**) *w^-^* eye clones in *Gadd45^+^* and *Gadd45^F17^* backgrounds. Dashed lines indicate clone boundaries. (**J**) Quantification of the fraction of the eye composed of *w^-^* cells in control and mutant eyes. p-values indicate differences between *Gadd45* mutant and control in the same NMD background (indicated by horizontal bars) or NMD mutant and control in the same *Gadd45* background (indicated by value above each individual bar), using a two-sided Student's t-test. ns indicates a p-value greater than 0.05. Error bars represent 2 SEM. n = 20 eyes for all conditions.**DOI:** [http://dx.doi.org/10.7554/eLife.12876.008](10.7554/eLife.12876.008)10.7554/eLife.12876.009Figure 2---figure supplement 1.Loss of *Gadd45* suppresses ectopic cell death in *Smg5* mutant wing discs.(**A** to **D**) DAPI (blue) and (**A'** to **D'**) TUNEL (red) staining in late 3^rd^ instar larval wing discs from *Smg5^G115/+^* (**A**); *Smg5^G115/C391^* (**B**); *Smg5^G115/+^ Gadd45^F17^* (**C**); and *Smg5^G115/C391^ Gadd45^F17^* (**D**) animals. *Smg5^G115^* and *Smg5^C391^* are null *Smg5* alleles (J.O.N. and M.M.M., unpublished). Scale bar represents 100 μm. (**E**) Relative TUNEL signal in wing discs, normalized to *Smg5^G115/+^*. p-values determined by two-sided Student's t-test between indicated conditions are displayed. ns indicates a p-value greater than 0.05. Error bars represent 2 SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.12876.009](10.7554/eLife.12876.009)

To test if *Gadd45*-induced cell death is the only cellular defect in NMD mutants, we examined NMD function in the developing eye. NMD is required for proper development of eye cells, as clonal patches of NMD mutant cells in eyes are reduced in size ([@bib12]; [@bib29]). We found that *Gadd45* is partially responsible for this defect, as the size of eye-cell clones lacking NMD activity in a *Gadd45^F17^* background was increased, although not fully restored ([Figure 2F--J](#fig2){ref-type="fig"}). These results indicate that some, but not all, defects associated with loss of NMD are dependent on *Gadd45*.

*Gadd45* is one of the few genes that is directly regulated by NMD in both flies and mammals ([@bib18]; [@bib41]; [@bib44]), raising the possibility that excess *Gadd45* abundance may also contribute to the NMD-mutant lethality observed in mammalian cells ([@bib2]; [@bib26]; [@bib27]; [@bib46]). To test this hypothesis, we analyzed the effects of *Gadd45* and *Upf1* depletion in mouse NIH-3T3 cells. *Gadd45b* mRNA (also known as *MyD118*), which is expressed at least 10-fold higher than any other *Gadd45* paralogue in these cells ([@bib49]), was degraded rapidly in a partially *Upf1*-dependent manner after transcription was blocked with actinomycin D ([Figure 3A](#fig3){ref-type="fig"}), and had increased expression during *Upf1* knockdown ([Figure 3D](#fig3){ref-type="fig"}), confirming it is sensitive to NMD. We found that transfection of 3T3 cells with siRNAs targeting *Upf1* resulted in significant reduction in cell counts after 48 hr ([Figure 3B](#fig3){ref-type="fig"}), but co-transfection with siRNAs targeting both *Upf1* and *Gadd45b* largely reversed this effect ([Figure 3B](#fig3){ref-type="fig"}). The reduction in cell counts was primarily due to increased cell death, as we found that \~25% of cells transfected with *Upf1* siRNA were undergoing apoptosis ([Figure 3C](#fig3){ref-type="fig"}). Co-transfection of siRNA targeting *Gadd45b* almost entirely eliminated this increase ([Figure 3C](#fig3){ref-type="fig"}), indicating the excess apoptosis observed in *Upf1*-knockdown cells was mostly due to increased *Gadd45* activity. However, while *Gadd45b* knockdown very greatly suppresses this excess death, it does not as fully rescue cell numbers, suggesting loss of NMD may lead to both Gadd45b-dependent cell death as well as a Gadd45b-independent effect on proliferation. This mirrors the conclusions we made about the partial suppression of cell number defects in the *Drosophila* eye. Importantly, *Upf1* mRNA expression was equivalently reduced and the expression of the mammalian endogenous NMD targets *Rassf1* and *CRCP* ([@bib41]) was equivalently increased in both the single and double knockdown experiments ([Figure 3D](#fig3){ref-type="fig"}), indicating that the restoration of viability was not due to a recovery of NMD pathway activity.10.7554/eLife.12876.010Figure 3.Gadd45b mediates cell lethality in Upf1 siRNA knockdown 3T3 mouse embryonic fibroblasts.(**A**) Relative *Gadd45b* mRNA expression measured by qRT-PCR in NIH-3T3 cells after 48 hr of control (black) or *Upf1* (red) siRNA treatment and 0 to 2 hr of actinomycin D treatment, normalized to expression prior to actinomycin treatment. The half-life calculated for each decay curve is indicated. (**B**) Relative viable cell count of *Upf1* and *Gadd45b* single and double siRNA treatment normalized to control siRNA. p-values display two-sided Student's t-test between indicated conditions. (**C**) Quantification of apoptosis as measured by annexin V staining. p-values display two-sided Student's t-test between indicated conditions. (**D**) Relative mRNA expression of *Upf1, Gadd45b*, and two mammalian endogenous NMD targets, *Rassf1* and *CRCP* ([@bib41]) measured by qRT-PCR in *Gadd45b* and *Upf1* single and double siRNA knockdown cells, normalized to expression in the control siRNA condition. p-values display one-sided Student's t-test for each condition compared to control. Error bars represent 2 SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.12876.010](10.7554/eLife.12876.010)10.7554/eLife.12876.011Figure 3---figure supplement 1.*GADD45A* mediates cell lethality in *Upf1* knockdown HEK293 cells.(**A**) Relative *GADD45A* mRNA expression measured by qRT-PCR in *UPF1* and *GADD45A* single and double siRNA knockdown 72 hr after siRNA transfection in HEK293 cells, normalized to expression in the control siRNA condition. p-values display one-sided Student's t-test for each condition compared to control. (**B**) Viable cell count of *UPF1* and *GADD45A* single and double siRNA-treated cells normalized to control siRNA -treated cells. p-values display two-sided Student's t-test between indicated conditions. (**C**) Relative *UPF1* mRNA expression measured by qRT-PCR in *UPF1* and *GADD45A* single and double siRNA knockdown, normalized to expression in control siRNA condition. p-values display one-sided Student's t-test for each condition compared to control. Error bars represent 2 SEM.**DOI:** [http://dx.doi.org/10.7554/eLife.12876.011](10.7554/eLife.12876.011)

To extend our analysis to other mammalian cells, we analyzed the role of *Gadd45* mediating the effects of loss of NMD in HEK293 cells. We found, similarly to 3T3 cells, that siRNA knockdown of *UPF1* in HEK293 cells led to increased *GADD45A* expression and reduced cell numbers compared to control siRNA ([Figure 3---figure supplement 1A,B](#fig3s1){ref-type="fig"}). Although transfection of siRNA targeting *GADD45A* alone slightly reduced HEK293 cell numbers, co-transfection with *UPF1* siRNA did not further reduce cell count ([Figure 3---figure supplement 1B](#fig3s1){ref-type="fig"}), and *UPF1* expression was equivalently reduced in the single and double knockdown conditions ([Figure 3---figure supplement 1C](#fig3s1){ref-type="fig"}). These results suggest that *UPF1* knockdown is no longer detrimental to HEK293 cell viability in the absence of *GADD45A* expression. We conclude that increased expression of mammalian *Gadd45* genes contributes to lethality in NMD-deficient mouse and human cells, as *Gadd45* does in *Drosophila*.

Deconvoluting the contributions to organismal viability of the PTC-surveillance versus gene-regulatory functions of NMD has been historically difficult ([@bib19]). Here, we show that viability can be restored to *Drosophila* lacking core NMD factors when a single endogenous NMD target, *Gadd45*, is eliminated, and that the requirement for the regulation of *Gadd45* by NMD is evolutionarily conserved from flies to mammals. Although our data suggest that up-regulation of *Gadd45* is a major factor contributing to lethality when NMD activity is lost, it is likely that other NMD targets also contribute to the observed lethality. In particular, viability is not restored to 100% in null *Upf1;* or *Upf2; Gadd45* double mutants. In addition, loss of *Gadd45* suppresses programmed cell death caused by defects in NMD, but not additional cell cycle defects, as implied by the incomplete suppression in the *Drosophila* eye and mammalian cell culture. Such defects in the cell cycle may be particularly pronounced during the development of certain tissue, or specific developmental stages. Indeed, NMD has been reported to have differing stage and tissue- specific activities ([@bib4]; [@bib5]; [@bib10]; [@bib26]). Whether this is due to a role in surveillance or another specific target remains unclear, but examination of the effects of loss of NMD in *Gadd45* mutants should allow exploration of these possibilities.

The benefit for such a mechanism regulating *Gadd45* expression may lie in a function of NMD in restricting viral growth ([@bib3]). Because viruses encode *trans*-acting factors to inhibit NMD ([@bib30]), the resulting accumulation of GADD45 in infected cells may act as a "molecular tripwire" that rapidly elicits a stress response and cell death. This outcome suggests that regulating responses to infection may underlie a conserved essential function of NMD. Intriguingly, restriction of pathogens via NMD extends to plants ([@bib13]), where NMD mutant lethality in *A. thaliana*, which do not encode *Gadd45* orthologues, may be caused by the overexpression of a subset of immune-related intracellular nucleotide-binding leucine-rich repeat receptors, some of which are endogenous NMD targets ([@bib15]). In contrast, eukaryotes that do not rely on the activation of programmed cell death to protect against viruses, such as *S. cerevisiae, S. pombe*, and *C. elegans*, do not require NMD for viability ([@bib17]; [@bib25]; [@bib28]). Together these observations suggest a potential novel role for NMD and *Gadd45* in immune responses, triggering the death of infected cells during pathogenic challenges.

Restoring the expression of PTC-containing alleles via NMD inhibition has been proposed as a promising therapy for a wide range of recessive genetic diseases ([@bib21]). Translation of stable PTC-containing mRNAs would produce truncated proteins that may be partially functional and alleviate disease symptoms normally caused by complete loss of the protein. However, the essential function for NMD in viability has raised the concern that these therapies may have prohibitive side effects. Our findings reveal a molecular basis for dealing with this obstacle by suggesting that inhibiting both the NMD and *Gadd45* pathways ([@bib42]) in combination could provide an effective and safe treatment for patients with debilitating genetic disorders.

Materials and methods {#s2}
=====================

Fly genetics {#s2-1}
------------

*Drosophila melanogaster* stocks were raised on standard cornmeal/dextrose food at 25°. The NMD mutant alleles *Upf2^25G^, Upf2^7-5A^,* and *Upf1^26A^*([@bib12]; [@bib29]) are on *y w FRT^19A^* chromosomes. These alleles were balanced over *FM7i, P{ActGFP}JMR3* ([@bib36]). *Smg5^G115^* and *Smg5^C391^* are null alleles of *Smg5* (J.O.N., D. Förster, S. Luschnig, and M.M.M., unpublished) and will be described in detail later. The *Smg5* alleles are balanced over *CyO, P{Dfd:eYFP w^+^}* ([@bib24]). Other alleles used were *P{w\[+mC\]=EPg}HP20647* ([@bib38]), *Mekk1^Ur36^*([@bib20]) recombined on *FRT^82B^*by D. Ryoo, *ey-FLP* ([@bib31]), *pcm^14^* ([@bib45]), *Adh^n4^*([@bib9]) and *DHR78^3^* ([@bib11]). Control chromosomes were *y w FRT^19A^* (for *Upf1* and *Upf2*) and *FRT^82B^* (for *Mekk1*) ([@bib48]). For all experiments using *Gadd45^F17^* we used the *Gadd45^E8^* precise excision as a control.

For viability assays, we mated flies for 3 days and collected all progeny each day for 10 days, starting 10 days after the cross was initiated. The total numbers of F1 mutant and balancer males were scored, and the ratio of mutant males to balancer males was used to determine mutant animal viability. To control for balancer viability within each experiment, we normalized the ratio of mutant to balancer animals to a ratio of the appropriate control chromosome to balancer animals produced from a parallel cross.

Deficiency suppressor screen {#s2-2}
----------------------------

We screened autosomal deficiencies from the DrosDel collection ([@bib37]). All deficiencies scored can be found in [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}. Deficiencies on chromosome 2 were balanced over *CyO*, and deficiencies on chromosome 3 were balanced over *TM6C*. We mated males from each deficiency stock to *y w Upf2^25G^ FRT^19A^/FM7i, P{ActGFP}JMR3* females and scored all F1 males for the presence or absence of each balancer. For any given deficiency tested, the percentage of *Deficiency / +* males that are *Upf2^25G^* mutants, less the percentage of *Balancer / +* males that are *Upf2^25G^* mutants was calculated, producing a Deficiency Suppression Score (DSS), which represents the effect of an individual deficiency on the increase or decrease in *Upf2^25G^* viability, while controlling for each deficiency's general influence on viability. A DSS greater than 0.1 indicates suppression of lethality. Supplemental deficiencies used were from the Exelixis collection ([@bib32]) and *Df(2R)sple-J1* ([@bib16]). Deficiency mapping to the *Drosophila* genome was performed using the 5.1 genome release.

RNA-seq data sets were acquired from [@bib8] (archives SRR896609, SRR896616, SRR503415, and SRR503416) and aligned using Bowtie and TopHat alignment with standard remapping parameters to the 5.1 *Drosophila* genome release. SAMtools accessory scripts were used to retrieve read counts for deficiency and control regions. All read counts were normalized to reads per million within each data set. Average normalized reads in *Upf2^25G^* samples were normalized to the relative reads of 74 ribosomal proteins in *Upf2^25G^* samples compared to control samples. Total normalized reads within the regions removed by each deficiency were averaged between biological replicates, and the difference between the *Upf2^25G^*and control samples was divided by one million to determine percent increase in genomic load across each deficiency region.

Generation of *Gadd45* mutants {#s2-3}
------------------------------

We produced P-element excision lines from the *P{w\[+mC\]=EPg}HP20647* P-element insertion line crossed to a *Δ2--3* transposase stock. We mated F1 males containing the P-element and transposase on a *CyO* balancer to *w; Tft / CyO* females. *Cy^+^ Tft* white-eyed F2 males were then individually mated to *w; Tft /* CyO females. We then collected *Tft^+^, Cy* males and females to create an isogenic stock from each individually mated F2 male. To identify precise excisions we used the primers Gadd45_F1 / Gadd45_R1 flanking the P-element insert site to amplify a region across the excised P-element. Lines that failed to amplify with these primers were candidate imprecise excisions, which we then tested with Gadd45_F1 / Gadd45_R3 primers for deletions. Any detected deletions were subsequently sequenced using these same primers. Primer sequences are found in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}.

Induction and analysis of eye clones {#s2-4}
------------------------------------

We generated eye clones with the FLP/FRT system using the *ey-FLP* driver ([@bib31]) to induce recombination. We imaged eyes on a Leica MZ125 stereo microscope with a Retiga-2000R camera (QImaging, Canada) with QCapture 3.1.2 software (QImaging). We focused images using the ImageJ stack focuser plugin and quantified relative eye clone size using the ImageJ analyzer tools. A total of 20 eyes from 20 individual animals were scored for each condition.

Cell death assays {#s2-5}
-----------------

For TUNEL assays, third instar larval wing discs were dissected as described in Sullivan *et al.* ([@bib39]). TUNEL staining was performed using the Apoptag Red in situ Apoptosis Detection Kit (Chimicon International Inc., Billerica, MA) according to Chakraborty *et al.* ([@bib7]). We DAPI stained wing discs (1:5000) for 5 min prior to mounting. Confocal images were acquired using a Zeiss LSM710 laser scanning confocal microscope (Carl Zeiss AG, Germany). 3-dimensional datasets were acquired with a Plan-Apochromat 20X/0.8 lens, 1.34 μm z-step, using the Zeiss ZEN software. To measure TUNEL signal intensity z-projections images were summed with ImageJ. Background signal was removed by using the ImageJ MaxEntropy auto-threshold. Relative total TUNEL signal intensity was calculated using the ImageJ analyzer tools to measure the total pixel intensity within the wing discs of TUNEL images and normalized to the average intensity in control conditions.

For annexin V staining, we collected media (including floating cells) from siRNA treated cells. We spun down media at 950g for 4 min to pellet cells, and then aspirated remaining media. Concurrently, we trypsinized siRNA-treated cells still on plates and added them to the same respective tube as previously spun-down media. Following the Alexa Fluor 488 Annexin V/Dead Cell Apoptosis Kit (Abcam, UK) protocol, we stained for apoptotic cells. We visualized cells on an Olympus IX51 microscope (Olympus, Japan) with 20X objective. We collected bright field as well as fluorescent images using a FITC filter with a QImaging QICam Fast1394 camera and QCaptureP software (QImaging). We analyzed cells by counting all cells within a bright field image as well as the annexin V positive cells from the same image. The number of annexin V positive cells was divided by total cell number to generate the fraction of apoptotic cells for each treatment. \>3000 total cells were counted across three biological replicates for each treatment.

Cell culture experiments {#s2-6}
------------------------

We cultured mouse NIH-3T3 cells (ATCC) or HEK293 cells (ATCC) in DMEM (Thermo-Fisher, Waltham, MA) supplemented with 10% fetal bovine serum and glutamine. For siRNA experiments, we transfected cells using RNAiMax and 24 pmol of negative control siRNA (Qiagen, Netherlands), *Upf1* siRNA (Qiagen), or *Gadd45b* siRNA (Sigma-Aldrich) for 3T3 cell experiments, or negative control siRNA (Qiagen), *UPF1* siRNA (Qiagen), or *GADD45A* siRNA (Sigma-Aldrich, St. Louis, MO) for HEK293 experiments. For double siRNA-treated cells, we used 24 pmol of each *Upf1* and *Gadd45b* siRNA for 3T3 experiments or *UPF1* and *GADD45A* siRNA for HEK293 experiments.

For actinomycin experiments, we incubated cells with siRNA for 48 hr before changing the media and then incubated with 2 μg/mL actinomycin (Sigma-Aldrich) for 1 or 2 hr. mRNA half-life was determined by fitting an exponential decay curve to the relative expression at each time point ([@bib41]). t~1/2~ was calculated based on the average expression at each time point, and the mean t~1/2~ for each condition is represented.

For cell counting experiments, we trypsinized cells, incubated a small aliquot with Trypan Blue at a final concentration of 0.04% in complete media, and counted Trypan Blue negative cells. RNA was collected from the remaining cells, and relative mRNA levels were measured as described below.

RNA isolation and quantitative RT-PCR {#s2-7}
-------------------------------------

For *Drosophila* qRT-PCR analyses, we collected 5--10 adult animals frozen in liquid nitrogen. We isolated total RNA using TRIzol reagent (Invitrogen) and phase-lock tubes (5-Prime), and the RNeasy mini kit (Qiagen). We used on-column RNase-free DNase treatment (Qiagen) to reduce genomic contamination. We determined RNA concentration by spectrophotometer and normalized concentration for reverse transcription. For reverse transcription, we used random decamers and MMLV8 reverse transcriptase (Retroscript Kit, Thermo-FIsher). We performed qRT-PCR analysis using the SYBR Green qPCR Supermix (Bio-Rad, Hercules, CA) and the Bio-Rad iCycler thermocycler. All experimental reactions were performed using three technical replicates and a minimum of three biological replicates per condition, and the expression level of all experimental assays was normalized to *RpL32* mRNA expression.

For cell culture qRT-PCR analyses, we collected RNA following the Zymo Research Quick RNA MiniPrep kits protocol, and synthesized cDNA using MMLV reverse transcriptase (NEB, Ipswich, MA) with a template of 1 µg of total RNA and priming with a T18 oligo. We measured relative mRNA levels by qRT-PCR using the Masterplex ep realplex (Eppendorf, Germany) with SYBR green fluorescent dye. Each sample was measured with technical triplicates and three biological replicates, and target mRNA levels were normalized to those of ribosomal protein 19 (*Rpl19*) mRNA.

For all qRT-PCR analyses we also measured samples that had been made without reverse transcriptase to ensure that signal was not due to genomic DNA. Primer sequences can be found in [Supplementary file 2](#SD2-data){ref-type="supplementary-material"}.

3' UTR cloning and sensitivity assay {#s2-8}
------------------------------------

We cloned the *UAS-GFP::Gadd45 3' UTR* and control *UAS-GFP::Act5C 3' UTR* constructs using the primers G45_3U_X1_F / G45_3U_S1_R or Act5C_X1_F / Act5C_S1_R ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}) to amplify the *Gadd45* and *Act5C* 3' UTRs, respectively, from genomic DNA. PCR fragments were inserted into the Zero Blunt TOPO vector (Thermo-Fisher), sequenced to assure fidelity, and digested and cloned into a pUAST-attB GFP vector using standard cloning procedures to replace the SV40 3' UTR. Plasmids were injected by BestGene (Chino Hills, CA) into a stock containing the VK00027 attP site ([@bib43]) for *phiC31* directed integration. We used previously described *UAS-GFP::SV40 3' UTR* animals ([@bib29]). For imaging, wandering late L3 larvae were collected and examined using a Leica MZ 16F microscope and the Leica DFC340 FX camera with the Leica Application Suite v3.3.0 software.

Analysis of *dHR78^3^* and *Adh^n4^* PTC allele stability {#s2-9}
---------------------------------------------------------

We collected adult F1 *Upf2^+^; Gadd45^E8/+^, Upf2^25G^; Gadd45^E8/+^*, and *Upf2^25G^; Gadd45^F17/+^*males that were also heterozygous for either the *dHR78^3^* or *Adh^n4^*. The *Adh^n4^*allele is a PTC-containing allele and has been demonstrated to be a direct NMD target based on cleavage by Smg6 ([@bib14]). The *dHR78^3^* allele is also a PTC-containing allele and thus is presumably degraded by NMD ([@bib11]). At least three biological replicates were collected for each condition. We isolated RNA and generated cDNA as described in methods above and used this cDNA as a template for PCR amplification of the *dHR78* transcript with the DRH78_F3 **/** DHR78_R3 primers and the *Adh* transcript with the Adh_F and Adh_R primers ([Supplementary file 2](#SD2-data){ref-type="supplementary-material"}), which flank the nonsense mutation in the respective transcripts. To compare the relative abundance of the *dHR78^3^* allele to the wild-type allele, PCR products were Sanger sequenced, and the relative peak intensity for a T (*dHR78^3^* allele) compared to a C (wild-type allele) at nucleotide 1063 was compared. To compare the relative abundance of the *Adh^n4^* allele to the wild-type allele, PCR products were digested with *Pvu*II (a site disrupted by the *n4* mutation), separated on a 1% agarose gel and stained with ethidium bromide. The relative intensity of the cut and uncut bands was determined using ImageJ and normalized for fragment length. All samples were ran on the same gel and compared under identical conditions. All ratios were normalized to the ratio in the *Upf2^25G^; Gadd45^E8/+^*condition.

Statistical analysis {#s2-10}
--------------------

All figures displaying viability assays represent a proportion of animals of the indicated genotypes that survive to adulthood; error bars for these figures represent the 95% confidence interval of the binomial distribution, and the Test of qual or Given Proportions was used to determine significance difference in these proportions between genotypes. All other figures represent the mean value of multiple replicates have error bars depicting ± 2 SEM, which is a close approximation of the 95% confidence interval ([@bib23]). For tests between two variable measures, a two-sided paired Student's t-test was used to determine significance difference between mean value data. For most qPCR experiments, data was compared to a normalized control, set to a constant of 1, so these tests were performed with a one-sided Student's t-test.
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In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your work entitled \"Degradation of a single mRNA by nonsense-mediated decay is essential for viability\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, with James Manley as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

A critical question in the RNA field is the functional significance of the nonsense-mediated RNA decay (NMD) pathway. NMD was originally discovered on the basis of its ability to degrade aberrant mRNAs (i.e., its RNA surveillance role) but was subsequently found to degrade many normal mRNAs (i.e., its gene expression role). Which is more important? With this elegant study, Mark Metzstein and colleagues take a great leap towards answering this question.

The authors sought to identify abnormally stabilized mRNAs that mediate lethality in NMD-defective *Drosophila melanogaster*. To this end, a genetic suppressor screen was performed in a *Drosophila* NMD mutant strain (hypomorphic *Upf2*^25G^ allele) and three candidate suppressing regions were identified. Two of these encompass the *Gadd45* and *Mekk1* genes, which operate in the same stress-response pathway. The importance of these genes for the NMD-lethality phenotype was analyzed further, and it was demonstrated that depletion of *Gadd45* in the *Upf2*^25G^-mutant completely restored viability, whereas it partially rescued viability in NMD null flies. Depletion of *Mekk1*, which acts downstream of *Gadd45* in the stress response, also increased viability, but to a lesser degree. Next, it was demonstrated that *Gadd45* is a direct target of NMD and that increased levels of *Gadd45* can explain the increased cells death observed in the *Upf2*^25G^-mutant.

Finally, the authors provided evidence that *Gadd45b* mRNA is also a direct NMD target in mouse NIH-3T3 cells and that its increased expression can partially explain the decreased viability observed in *UPF1*-depleted cells.

These observations led the authors to conclude that the essentiality of NMD in *Drosophila* and mammals in essence resides in the down-regulation of a single gene (*Gadd45*), which is involved in induction of apoptosis. The presented results, coupled with the finding of others that viral infection suppresses NMD, made the authors propose an interesting model in which NMD provides defense against virus infection by killing virally infected cells.

Essential revisions:

Overall, this study represents an important advance for the RNA/NMD field. Publication in *eLife* is therefore suggested if the authors can substantiate their conclusions. In its present form, the main conclusion (including the title) appears to be going somewhat too far. Several of the authors\' own observations point to additional contributions to lethality besides higher *Gadd45* expression -- except in the specific *Upf2*^25G^-mutant.

1\) It is important to prove that the observed effects are coupled to increased *Gadd45* protein. The authors need to show that expression of the *Gadd45* protein is increased in *Upf2*^25G^ and perhaps also other NMD-defective cells.

2\) [Figure 2](#fig2){ref-type="fig"}. It is critical that the authors examine suppression of apoptosis by *Gadd45* in *Upf1*-mutant flies (e.g., *Upf1^26A^*), not just *Upf2*-mutant flies (as both were examined in [Figure 1](#fig1){ref-type="fig"}). Given that NMD factors can function in pathways other than NMD, it is essential to assess more than one NMD factor.

3\) Conservation in mammals. The results in [Figure 3](#fig3){ref-type="fig"} are intriguing, but require some bolstering.

A\) The mechanism underlying the alterations in cell counts must be investigated. Is it the result of alterations in cell death, proliferation, or both? Is the *Gadd45*-dependent apoptosis phenotype conserved in mammals?

B\) At least one more cell line should be used for at least some experiments (one cell line is not enough to be convincing).

C\) Given that there are several *Gadd45* genes in mammals, it is important that these also be investigated. While it is appreciated that *Gadd45b* is the most highly expressed *Gadd45* gene in NIH-3T3 cells, this does not rule out the importance of the other *Gadd45* genes. Perhaps try the triple knockdown of *Gadd45A, B* and *G. GADD45A* appears to be the highest expressed variant in HEK293 and HeLa cells, so one or both of these cell lines could be obvious additional cell lines to test.

D\) [Figure 3A](#fig3){ref-type="fig"}. One time point is not sufficient for RNA half-life analysis.

E\) [Figure 3C](#fig3){ref-type="fig"}. More NMD substrates besides *Smg5* should be used for this analysis. Indeed, the effect on *Smg5* is very modest (probably because of either insufficient NMD factor knockdown or poor transfection efficiency). A lack of an effect on some NMD substrates is ok given the heterogeneity of the NMD pathway, but at least one NMD substrate should have a greater effect than only 50%. A cell line with greater transfection efficiency than NIH-3T3 might be necessary to use. The GAS5 non-coding RNA could be a possible candidate to check since it appears to be highly responsive to NMD in both human and mouse cells.

4\) Although it is very clear that *Gadd45* stabilization is a major determinant for the lethality phenotype of the *Upf2*^25G^-mutant *Drosophila* strain and the decreased viability phenotype in *UPF1*-depleted NIH-3T3 cells, it is also clear that increased levels of *Gadd45* cannot fully explain the lethality of NMD null mutant flies. Therefore, there must be other transcripts at play. One possibility is that NMD is vital for different stages of development, as e.g. indicated by several NMD knockout mouse studies. The authors should discuss more thoroughly the possibility that different stages of development may be affected by abnormal high expression of other factors than *Gadd45*. Generally, the conclusions (incl. the title) should be somewhat toned down, because overexpression of *Gadd45* cannot fully explain lethality of all NMD-mutants. In relation to this: does the third deleted region contain genes that are related to the *Gadd45* pathway or are they unrelated? In case of the latter, this also points to other contributors to lethality.

10.7554/eLife.12876.017

Author response

*1) It is important to prove that the observed effects are coupled to increased Gadd45 protein. The authors need to show that expression of the Gadd45 protein is increased in Upf2^25G^ and perhaps also other NMD-defective cells.*

We could not directly address Gadd45 protein expression in *Upf2^25G^* flies because no antibodies that suitably detect *Drosophila* Gadd45 protein exist. We attempted to detect *Drosophila* Gadd45 using a broadly reacting antisera directed against HumanGADD45β, however, we found that this antibody does not cross-react with *Drosophila* Gadd45 protein. In addition, we tried to use this antisera in our mammalian cell culture, and also could not detect expression of endogenous Gadd45b (in the literature developed antibodies have only been tested on cells over-expressing Gadd45). However, since our data indicates that the loss of *Mekk1* shows similar effects to loss of *Gadd45* and that Gadd45 is known to regulate *Mekk1* by a protein-protein interaction strongly suggests that Gadd45 protein levels must be increased in NMD mutants, even in the absence of a direct assay of Gadd45 protein levels in *Drosophila*. Furthermore, we show that a GFP reporter with the *Gadd45* 3' UTR has increased fluorescence in *Upf2^25G^* mutants, also suggesting that transcripts with the *Gadd45* 3'UTR have increased protein levels in NMD mutants.

*2) [Figure 2](#fig2){ref-type="fig"}. It is critical that the authors examine suppression of apoptosis by Gadd45 in Upf1-mutant flies (e.g., Upf1^26A^), not just Upf2-mutant flies (as both were examined in [Figure 1](#fig1){ref-type="fig"}). Given that NMD factors can function in pathways other than NMD, it is essential to assess more than one NMD factor.*

We agree with the reviewers that it is important to test if loss of *Gadd45* suppresses cell death in other NMD mutants, such as *Upf1* or *Upf2* null alleles. However, we have previously found that such mutants die during early larval stages(Chapin et al. 2014) and we were not able to isolate discs from these animals to examine cell death. Instead, we turned to another critical NMD gene, *Smg5*. In work we are currently preparing for publication we show that *Drosophila Smg5* is critical for NMD function and viability, similar to *Upf1* and *Upf2*, but *Smg5* mutants die at a later stage. We examined TUNEL signal in the wing discs of *Smg5* null mutants and found it is increased compared to controls and that *Gadd45* mutants suppressed this ectopic cell death, very similarly to what we found in *Upf2^25G^* mutant discs. This result indicates that the cell death in *Upf2* mutant wing discs is in fact a defect due to loss of NMD pathway function and not the loss of NMD-independent *Upf2* function. We are presenting this data in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}. As a technical note, when analyzing the *Smg5* wing discs our reagents lead to higher background signal than the previous experiments, so we had to adapt our quantification procedure (as described in the Methods section). In the interest of consistency, we reanalyzed our *Upf2^25G^* data using this new approach and obtained essentially identical results to before. We have updated [Figure 2](#fig2){ref-type="fig"} to represent this new analysis.

*3) Conservation in mammals. The results in [Figure 3](#fig3){ref-type="fig"} are intriguing, but require some bolstering.*

*A) The mechanism underlying the alterations in cell counts must be investigated. Is it the result of alterations in cell death, proliferation, or both? Is the Gadd45-dependent apoptosis phenotype conserved in mammals?*

We have examined the mechanism for cell count changes by staining cells for the apoptotic marker annexin V. We find that Upf1 knockdown cells show a large increase in apoptosis, and this increase is almost entirely suppressed by simultaneous knockdown of *Gadd45b*. However, the increase in cell death probably does not alone account for the decrease in cell numbers, suggesting an underlying proliferation defect also occurs in NMD knockdown. Since *Gadd45b* knockdown appears to totally eliminate the apoptosis defect in NMD knockdown cells, but does not fully rescue cell numbers, this further suggests *Gadd45b* overexpression may not be responsible for the proliferation defect. We come to similar conclusions from *Drosophila* eye analysis. We have included these data in [Figure 3](#fig3){ref-type="fig"}, and in the Discussion (this is also relevant to comment 4, below)

*B) At least one more cell line should be used for at least some experiments (one cell line is not enough to be convincing).*

We have repeated our experiments using human HEK293 cells and obtained very similar results. These are shown in [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.

*C) Given that there are several Gadd45 genes in mammals, it is important that these also be investigated. While it is appreciated that Gadd45b is the most highly expressed Gadd45 gene in NIH-3T3 cells, this does not rule out the importance of the other Gadd45 genes. Perhaps try the triple knockdown of Gadd45A, B and G. GADD45A appears to be the highest expressed variant in HEK293 and HeLa cells, so one or both of these cell lines could be obvious additional cell lines to test.*

We have attempted multiple Gadd45 knockdowns in both 3T3 and HEK cells, but we have found these to have deleterious effects on cell survival on their own, greatly convoluting our analysis of suppression of NMD knockdown. In these experiments we did find, as predicted by the reviewers, that GADD45A seems to primarily mediate the NMD knockdown response in HEK cells, so it is indeed the case that the predominantly expressed Gadd45 that seems to mediate NMD knockdown effects. However, since we show that we can rescue NMD cells by knockdown of a single homolog in both cell types, we believe the conclusions we present in the manuscript are valid. Knockdown of multiple Gadd45 paralogs, if it were possible, would be expected to further improve NMD cell survival, strengthening our conclusion, but the negative result of no increased survival would not suggest an alternative model.

*D) [Figure 3A](#fig3){ref-type="fig"}. One time point is not sufficient for RNA half-life analysis.*

We have added an additional time point and used this to calculate RNA half-life directly. This is presented as a revised panel in [Figure 3A](#fig3){ref-type="fig"}.

*E) [Figure 3C](#fig3){ref-type="fig"}. More NMD substrates besides Smg5 should be used for this analysis. Indeed, the effect on Smg5 is very modest (probably because of either insufficient NMD factor knockdown or poor transfection efficiency). A lack of an effect on some NMD substrates is ok given the heterogeneity of the NMD pathway, but at least one NMD substrate should have a greater effect than only 50%. A cell line with greater transfection efficiency than NIH-3T3 might be necessary to use. The GAS5 non-coding RNA could be a possible candidate to check since it appears to be highly responsive to NMD in both human and mouse cells.*

We have replaced the weakly affected *Smg5* with two other substrates whose RNA levels are more than two-fold affected by NMD knockdown. We would have liked to have tested GAS5 directly, but all our current samples are polyA selected, so we unfortunately do not have this RNA represented.

4\) Although it is very clear that Gadd45 stabilization is a major determinant for the lethality phenotype of the Upf2^25G^-mutant Drosophila strain and the decreased viability phenotype in UPF1-depleted NIH3T3 cells, it is also clear that increased levels of Gadd45 cannot fully explain the lethality of NMD null mutant flies. Therefore, there must be other transcripts at play. One possibility is that NMD is vital for different stages of development, as e.g. indicated by several NMD knockout mouse studies. The authors should discuss more thoroughly the possibility that different stages of development may be affected by abnormal high expression of other factors than Gadd45. Generally, the conclusions (incl. the title) should be somewhat toned down, because overexpression of Gadd45 cannot fully explain lethality of all NMD-mutants. In relation to this: does the third deleted region contain genes that are related to the Gadd45 pathway or are they unrelated? In case of the latter, this also points to other contributors to lethality.

The reviewers make valid points about the likelihood of additional factors contributing to lethality in NMD mutant animals. We have incorporated these suggestions into the Discussion, and modified our title to "Degradation of *Gadd45* mRNA by nonsense-mediated decay is essential for viability", which more explicitly refers to the necessity of *Gadd45* regulation by NMD. In addition, our data suggests that loss of NMD causes defects in cell survival via GADD45 upregulation, but also defects in the cell cycle independent of Gadd45. These latter defects do not always lead to cell lethality, but may contribute to the lower viability observed in NMD null mutants even with *Gadd45* deleted. These points have been added to the Discussion.

Preliminary analysis of the third region indicates that suppression is likely due to multiple loci, and it is unclear if these loci function on the *Gadd45* pathway (like *Mekk1*) or are independently regulated by NMD. We are continuing to analyze genes in this region and will report on it in a future publication.
